Literature DB >> 24473482

Spatial distribution of perfusion abnormality in acute MCA occlusion is associated with likelihood of later recanalization.

Susanne Siemonsen1, Nils Daniel Forkert2, Anne Hansen1, Andre Kemmling1, Götz Thomalla3, Jens Fiehler1.   

Abstract

The aim of this study is to investigate whether different spatial perfusion-deficit patterns, which indicate differing compensatory mechanisms, can be recognized and used to predict recanalization success of intravenous fibrinolytic therapy in acute stroke patients. Twenty-seven acute stroke data sets acquired within 6 hours from symptom onset including diffusion- (DWI) and perfusion-weighted magnetic resonance (MR) imaging (PWI) were analyzed and dichotomized regarding recanalization outcome using time-of-flight follow-up data sets. The DWI data sets were used for calculation of apparent diffusion coefficient (ADC) maps and subsequent infarct core segmentation. A patient-individual three-dimensional (3D) shell model was generated based on the segmentation and used for spatial analysis of the ADC as well as cerebral blood volume (CBV), cerebral blood flow, time to peak (TTP), and mean transit time (MTT) parameters derived from PWI. Skewness, kurtosis, area under the curve, and slope were calculated for each parameter curve and used for classification (recanalized/nonrecanalized) using a LogitBoost Alternating Decision Tree (LAD Tree). The LAD tree optimization revealed that only ADC skewness, CBV kurtosis, and MTT kurtosis are required for best possible prediction of recanalization success with a precision of 85%. Our results suggest that the propensity for macrovascular recanalization after intravenous fibrinolytic therapy depends not only on clot properties but also on distal microvascular bed perfusion. The 3D approach for characterization of perfusion parameters seems promising for further research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24473482      PMCID: PMC4013754          DOI: 10.1038/jcbfm.2014.13

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  37 in total

Review 1.  Collateral circulation.

Authors:  David S Liebeskind
Journal:  Stroke       Date:  2003-07-24       Impact factor: 7.914

2.  Measurement of the ischemic penumbra with MRI: it's about time.

Authors:  Steven Warach
Journal:  Stroke       Date:  2003-09-11       Impact factor: 7.914

3.  Prognostic value of perfusion- and diffusion-weighted MR imaging in first 3 days of stroke.

Authors:  M Kluytmans; K J van Everdingen; L J Kappelle; L M Ramos; M A Viergever; J van der Grond
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

4.  Perfusion-weighted imaging-derived collateral flow index is a predictor of MCA M1 recanalization after i.v. thrombolysis.

Authors:  F Nicoli; P Lafaye de Micheaux; N Girard
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-05       Impact factor: 3.825

5.  Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited.

Authors:  Colin P Derdeyn; Tom O Videen; Kent D Yundt; Susanne M Fritsch; David A Carpenter; Robert L Grubb; William J Powers
Journal:  Brain       Date:  2002-03       Impact factor: 13.501

6.  Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Authors:  Randall T Higashida; Anthony J Furlan; Heidi Roberts; Thomas Tomsick; Buddy Connors; John Barr; William Dillon; Steven Warach; Joseph Broderick; Barbara Tilley; David Sacks
Journal:  Stroke       Date:  2003-07-17       Impact factor: 7.914

7.  Predictors of apparent diffusion coefficient normalization in stroke patients.

Authors:  Jens Fiehler; Karina Knudsen; Thomas Kucinski; Chelsea S Kidwell; Jeffry R Alger; Götz Thomalla; Bernd Eckert; Oliver Wittkugel; Cornelius Weiller; Hermann Zeumer; Joachim Röther
Journal:  Stroke       Date:  2004-01-22       Impact factor: 7.914

8.  Perfusion thresholds in acute stroke thrombolysis.

Authors:  K Butcher; M Parsons; T Baird; A Barber; G Donnan; P Desmond; B Tress; S Davis
Journal:  Stroke       Date:  2003-07-31       Impact factor: 7.914

9.  Detecting the subregion proceeding to infarction in hypoperfused cerebral tissue: a study with diffusion and perfusion weighted MRI.

Authors:  Y Liu; J O Karonen; R L Vanninen; J Nuutinen; J Perkiö; P A Vainio; S Soimakallio; H J Aronen
Journal:  Neuroradiology       Date:  2003-05-16       Impact factor: 2.804

10.  Assessing tissue viability with MR diffusion and perfusion imaging.

Authors:  Pamela W Schaefer; Yelda Ozsunar; Julian He; Leena M Hamberg; George J Hunter; A Gregory Sorensen; Walter J Koroshetz; R Gilberto Gonzalez
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

View more
  4 in total

1.  Multivariate dynamic prediction of ischemic infarction and tissue salvage as a function of time and degree of recanalization.

Authors:  André Kemmling; Fabian Flottmann; Nils Daniel Forkert; Jens Minnerup; Walter Heindel; Goetz Thomalla; Bernd Eckert; Michael Knauth; Marios Psychogios; Soenke Langner; Jens Fiehler
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-08       Impact factor: 6.200

2.  Multiclass Support Vector Machine-Based Lesion Mapping Predicts Functional Outcome in Ischemic Stroke Patients.

Authors:  Nils Daniel Forkert; Tobias Verleger; Bastian Cheng; Götz Thomalla; Claus C Hilgetag; Jens Fiehler
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

3.  Improved multi-parametric prediction of tissue outcome in acute ischemic stroke patients using spatial features.

Authors:  Malte Grosser; Susanne Gellißen; Patrick Borchert; Jan Sedlacik; Jawed Nawabi; Jens Fiehler; Nils Daniel Forkert
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

4.  Localized prediction of tissue outcome in acute ischemic stroke patients using diffusion- and perfusion-weighted MRI datasets.

Authors:  Malte Grosser; Susanne Gellißen; Patrick Borchert; Jan Sedlacik; Jawed Nawabi; Jens Fiehler; Nils D Forkert
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.